Epidemiology of heart failure in mainland Portugal: New data from the EPICA study;Epidemiologia da insuficiência cardíaca em portugal continental: Novos dados do estudo EPICA

Revista Portuguesa de Cardiologia

Volumn 23, Issue SUPPL. 3, 2004, Pages

  Ceia, Fátima ^a,b   Fonseca, Cândida ^a   Mota, Teresa ^a   Morais, Humberto ^a   Matias, Fernando ^a   Costa, Catarina ^a   Gouveia Oliveira, António ^a  

^a Grupo de Investigacao EPICA   (Portugal)

^b HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

Author keywords

Diagnosis; Heart failure; Preserved systolic function; Primary Care; Systolic dysfunction

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; THIAZIDE DIURETIC AGENT;

CLINICAL FEATURE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; HEART DISEASE; HEART FAILURE; HUMAN; OBESITY; PORTUGAL; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SINUS RHYTHM;

HEART FAILURE, CONGESTIVE; HUMANS; PORTUGAL; PREVALENCE;

EID: 4944221651     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Abreu e Lima C. Epidemiology of heart failure and ventricular dysfunction. In L. Menezes-Falcão and Peter van Zwieten, Current diagnosis and treatment in heart failure. Lidel Edições Técnicas, Lisboa, 2001, pp. 5-19.
2. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001;104:2996-3007.
3. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: W. J. Remme and K. Swedberg. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
4. Cleland JGF. Screening for left ventricular dysfunction and chronic heart failure. Should it be done and, if so, how? Dis Manage Health Outcomes 1997;4:169-84.
5. Fonseca C, Mota T, Matias F, Morais H, Sousa A, Gouveia-Oliveira A, Ceia F, on behalf of EPICA investigators. Validation and performance of structured questionnaires for the diagnosis of heart failure in the Portuguese population. Eur J Heart Fail 2000;2(supll.2):73.
6. Cleland JGF, Erdmann E, Ferrari R, Hess OM, Poole-Wilson PA, Remme WJ et al. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
7. Carlson KJ, Lee DC-S, Goroll AH, Leahy M, Johnson RA. An analysis of physician's reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 1985;38:733-9.
8. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, Gouveia-Oliveira A, on behalf of the EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002;4:531-9.
9. Fonseca C. Prévalence de l'insuffisance cardiaque au Portugal. Rev Por Cardiol 1999;18:1151-5.
10. Mota T, Fonseca C, Matias F, Morais H, Sousa A, Gouveia-Oliveira A, Ceia F, on behalf of EPICA investigators. Management of heart failure in Portuguese primary care. Eur J Heart Fail 2000;2 (suppl.2):25.
11. Fonseca C, Mota T, Matias F, Morais H, Sousa A, Costa C, Gouveia-Oliveira A, Ceia F, on behalf of EPICA investigators. Performance and concordance of clinical scores in the diagnosis of heart failure in primary care. JACC 2002;39 (supl. B): 375-B.
12. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-23.
13. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352 (suppl I):3-7.
14. Stewart S, MacIntyre K, MacLeod MMC, Bailey AEM, Capewell S, McMurray JJV. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J 2001;22:209-17.
15. Vasan RF, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
16. Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction. Is it really a disorder of diastolic function?. Circulation 2003;107:656-8.
17. Vasan RS, Larson MJ, Benjamin EJ, Evans JC, Reiss CK Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
18. Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R et al. Congestive heart failure despite normal left ventricular systolic function in a population.based sample: the Strong Heart Study. Am J Cardiol 2000;861090-1096.
19. Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 2001;38:1277-282.
20. Varadarajan P, Pai RG. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. Journal of Cardiac Failure 2003;9:107-12.
21. Gottdiener JS, McClelland RL, Shemansky L, Furberg CD, Kitzman DW, Cushman M, Polak J, Gardin JM, Gersh BJ, Aurigemma GP, Manolio TA. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. Ann Intern Med 2002;137:631-9.